Cargando…
Ultra-long-acting removable drug delivery system for HIV treatment and prevention
Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formula...
Autores principales: | Kovarova, Martina, Benhabbour, S. Rahima, Massud, Ivana, Spagnuolo, Rae Ann, Skinner, Brianna, Baker, Caroline E., Sykes, Craig, Mollan, Katie R., Kashuba, Angela D. M., García-Lerma, J. Gerardo, Mumper, Russell J., Garcia, J. Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175887/ https://www.ncbi.nlm.nih.gov/pubmed/30297889 http://dx.doi.org/10.1038/s41467-018-06490-w |
Ejemplares similares
-
Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
por: Benhabbour, S. Rahima, et al.
Publicado: (2019) -
A new engineering process of biodegradable polymeric solid implants for ultra-long-acting drug delivery
por: Maturavongsadit, Panita, et al.
Publicado: (2020) -
Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection
por: Young, Isabella C., et al.
Publicado: (2023) -
Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming Implant
por: Young, Isabella C., et al.
Publicado: (2023) -
Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
por: Feng, Lan, et al.
Publicado: (2011)